Doklady Biological Sciences

, Volume 394, Issue 1–6, pp 1–3 | Cite as

Effects of Semax on Dopaminergic and Serotoninergic Systems of the Brain

  • K. O. Eremin
  • V. S. Kudrin
  • I. A. Grivennikov
  • N. F. Miasoedov
  • K. S. Rayevsky
Article

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Ashmarin, I.P., Nezavibat'ko, V.N., Myasoedov, N.F., et al., Zh. Vyssh. Nervn. Deyat., 1997, vol. 47, no. 2, pp. 420-430.Google Scholar
  2. 2.
    Kaplan, A.Ya., Kochetova, A.G., Nezavibathko, V.N., et al., Neurosci. Res. Commun., 1996, vol. 19, no. 2, pp. 115-123.Google Scholar
  3. 3.
    Adan, R.A.H., Oosterom, J., and Ludvigsdottir, G., et al., Eur. J. Pharmacol., 1994, vol. 269, pp. 331-337.Google Scholar
  4. 4.
    Adan, R.A.H. and Gispen, W.H., Peptides, 1997, vol. 18, no. 8, pp. 1279-1287.Google Scholar
  5. 5.
    Adan, R.A.H. and Gispen, W.H., Eur. J. Pharmacol., 2003, vol. 405, pp. 13-24.Google Scholar
  6. 6.
    Florijn, W.J., Holtmaat, A.J., de Lang, H., et al., Brain Res., 1993, vol. 625, no. 1, pp. 169-172.Google Scholar
  7. 7.
    Kudrin, V.S., Sergeeva, S.A., Krasnykh, L.M., et al., Eksp. Klin. Farmakol., 1995, vol. 58, no. 4, pp. 8-11.Google Scholar
  8. 8.
    Anderzhanova, E.A., Rayevsky, K.S., Saransaari, P., et al., Eur. J. Pharmacol., 2001, vol. 428, pp. 87-95.Google Scholar
  9. 9.
    Eremin, K.O., Kudrin, V.S., Andreeva, L.A., et al., Neirokhimiya, 2002, vol. 19, no. 4, pp. 269-272.Google Scholar
  10. 10.
    Chaki, S., Hirota, S., Funakoshi, T., et al., J. Pharm. Exp. Ther., 2003, vol. 304, no. 2, pp. 818-826.Google Scholar

Copyright information

© MAIK “Nauka/Interperiodica” 2004

Authors and Affiliations

  • K. O. Eremin
    • 1
  • V. S. Kudrin
    • 1
  • I. A. Grivennikov
    • 2
  • N. F. Miasoedov
    • 2
  • K. S. Rayevsky
  1. 1.Research Institute of PharmacologyMoscowRussia
  2. 2.Institute of Molecular GeneticsMoscowRussia

Personalised recommendations